Status:
COMPLETED
Impact of Insecticide-treated Curtains on Antimalarial Drug Resistance
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Conditions:
Malaria
Eligibility:
All Genders
6-59 years
Phase:
NA
Brief Summary
Attempts to understand the relationship malaria transmission intensity and antimalarial drug resistance had rested mainly on mathematical models. To date, except for two studies which reported reducti...
Detailed Description
1. Background Drug resistance has been associated with increased numbers of hospital admissions, increased cases of clinical malaria and malaria-specific mortality . Several strategies have been p...
Eligibility Criteria
Inclusion
- Age between 6 and 59 months Mono infection with P.falciparum malaria, with parasitaemia in the range of 1,000 to 150,000 parasites per ml Absence of danger signs or signs of severe malaria. Axillary temperature \>= 37.5 ºC. Absence of signs of severe malnutrition. Absence of any obvious cause of fever other than malaria. No history of allergy to CQ. Willingness to return to the health facility for follow-up. Informed consent obtained from the caretaker of the child
Exclusion
- Danger signs of severe or complicated malaria, persisted vomiting. Received treatment with an antimalarial drug other than CQ in the last 2 weeks. Caretaker did not sign the consent form
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2002
Estimated Enrollment :
1035 Patients enrolled
Trial Details
Trial ID
NCT00169078
Start Date
July 1 2002
End Date
December 1 2002
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre National de Recherche et de Formation sur le Paludisme
Ouagadougou, Kadiogo, Burkina Faso, 2208